Observational Study of Pediatric Rheumatic Disease
About the Study
Currently Recruiting: Participants
Study Drug/Intervention: Observational Registry
Study Timeline: This study is expected to conclude in December 2028.
ClinicalTrials.gov ID: NCT02418442
Study Objectives
- Prospectively collect essential data from children, adolescents and young adults with pediatric onset rheumatic diseases.
- Evaluate the safety of therapeutic agents in persons with pediatric onset rheumatic diseases.
Participation Criteria
- Onset of rheumatic disease prior to age 16 years for juvenile idiopathic arthritis and onset prior to age 19 years for all other rheumatic diseases
- Subject and/or parent/legal guardian is able to provide written informed consent and willing to comply with study procedures
- Subject and/or parent/ legal guardian is willing to be contacted in the future by study staff
Sponsor/Funding
Childhood Arthritis and Rheumatology Research Alliance (CARRA)
Learn More
- PI: Mara Becker, MD, MSCE
- PL: Anne Dennos; Chetna Godiwala